Published in Nature on June 29, 1989
Rapid and efficient site-directed mutagenesis by single-tube 'megaprimer' PCR method. Nucleic Acids Res (1997) 2.38
Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Sci U S A (1989) 1.68
A faster-acting and more potent form of tissue plasminogen activator. Proc Natl Acad Sci U S A (1994) 1.52
Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc Natl Acad Sci U S A (1992) 1.45
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A (1990) 1.13
Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA. EMBO J (1997) 1.08
Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc Natl Acad Sci U S A (2003) 1.05
Blood-brain barrier permeability and tPA-mediated neurotoxicity. Neuropharmacology (2010) 1.00
Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation. Biochem J (1992) 0.98
Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor. Proc Natl Acad Sci U S A (1990) 0.96
Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1. J Biol Chem (2011) 0.96
Regulation of airway contractility by plasminogen activators through N-methyl-D-aspartate receptor-1. Am J Respir Cell Mol Biol (2010) 0.93
Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa. J Biol Chem (2008) 0.93
Molecular basis for the resistance of an insect chymotrypsin to a potato type II proteinase inhibitor. Proc Natl Acad Sci U S A (2010) 0.85
Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building. Protein Sci (1996) 0.83
Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa. J Biol Chem (2010) 0.81
Role of residue Y99 in tissue plasminogen activator. Protein Sci (2000) 0.80
Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases. BMC Biochem (2003) 0.78
Short-lived protease serpin complexes: partial disruption of the rat trypsin active site. Protein Sci (2007) 0.78
Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1. J Biol Chem (2015) 0.78
Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1. Proc Natl Acad Sci U S A (1997) 0.77
Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1. Data Brief (2016) 0.75
alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1. Protein Sci (2002) 0.75
Biophysical Mechanisms Mediating Fibrin Fiber Lysis. Biomed Res Int (2017) 0.75
Recombinant natural anticoagulants: a review. J R Soc Med (1992) 0.75
Studies of serpins unfold at a feverish pace. J Clin Invest (1994) 0.75
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport. Cell (1986) 9.16
The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature (1988) 7.98
A transmembrane protein with a cdc2+/CDC28-related kinase activity is required for signaling from the ER to the nucleus. Cell (1993) 6.82
How MAP kinases are regulated. J Biol Chem (1995) 6.04
Expression of early genes of origin-defective mutants of simian virus 40. Proc Natl Acad Sci U S A (1980) 5.33
Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell (1978) 5.23
Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature (1994) 4.97
Cloning and DNA sequence of double-stranded copies of haemagglutinin genes from H2 and H3 strains elucidates antigenic shift and drift in human influenza virus. Nature (1980) 4.90
Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol (1994) 4.65
S. cerevisiae encodes an essential protein homologous in sequence and function to mammalian BiP. Cell (1989) 4.28
Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell (1997) 4.26
WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem (2000) 3.97
Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell (1993) 3.93
Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A (1993) 3.92
Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein. Nature (1982) 3.74
A strong suppressor specific for UGA. Nature (1967) 3.73
T antigen and template requirements for SV40 DNA replication in vitro. EMBO J (1985) 3.59
Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol (1986) 3.56
A 22 bp cis-acting element is necessary and sufficient for the induction of the yeast KAR2 (BiP) gene by unfolded proteins. EMBO J (1992) 3.48
Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A (1978) 3.42
Haemagglutinin of influenza virus expressed from a cloned gene promotes membrane fusion. Nature (1982) 3.39
Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene. Nature (1981) 3.29
The promoter region of the yeast KAR2 (BiP) gene contains a regulatory domain that responds to the presence of unfolded proteins in the endoplasmic reticulum. Mol Cell Biol (1993) 3.25
New host cell system for regulated simian virus 40 DNA replication. Mol Cell Biol (1985) 2.82
Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. Structure (1994) 2.80
Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev (1987) 2.64
Mutations in the cytoplasmic domain of the influenza virus hemagglutinin affect different stages of intracellular transport. J Cell Biol (1985) 2.60
Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli. J Virol (1994) 2.56
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell (1983) 2.54
Heterologous transmembrane and cytoplasmic domains direct functional chimeric influenza virus hemagglutinins into the endocytic pathway. J Cell Biol (1986) 2.37
Structural basis of latency in plasminogen activator inhibitor-1. Nature (1992) 2.33
Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J Biol Chem (1992) 2.19
Structural changes in glycogen phosphorylase induced by phosphorylation. Nature (1988) 2.16
Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket. J Biol Chem (1998) 2.12
Common and divergent peptide binding specificities of hsp70 molecular chaperones. J Biol Chem (1994) 2.11
Cytotoxic T lymphocyte recognition of the influenza hemagglutinin gene product expressed by DNA-mediated gene transfer. J Exp Med (1984) 2.10
Modeling of the spatial structure of eukaryotic ornithine decarboxylases. Protein Sci (1995) 2.02
Variant influenza virus hemagglutinin that induces fusion at elevated pH. J Virol (1986) 2.00
Analysis of progressive deletions of the transmembrane and cytoplasmic domains of influenza hemagglutinin. J Cell Biol (1986) 1.94
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation (1997) 1.91
Structural basis of inhibitor selectivity in MAP kinases. Structure (1998) 1.89
The structure of mitogen-activated protein kinase p38 at 2.1-A resolution. Proc Natl Acad Sci U S A (1997) 1.83
Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem (1988) 1.81
Influenza virus RNA segment 7 has the coding capacity for two polypeptides. Virology (1980) 1.80
Formation of protein micelles from amphiphilic membrane proteins. Proc Natl Acad Sci U S A (1978) 1.80
Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. Proc Natl Acad Sci U S A (2001) 1.66
Lines of BPV-transformed murine cells that constitutively express influenza virus hemagglutinin. EMBO J (1985) 1.66
Translocation in yeast and mammalian cells: not all signal sequences are functionally equivalent. J Cell Biol (1987) 1.59
Cloned copy of the haemagglutinin gene codes for human influenza antigenic determinants in E. coli. Nature (1981) 1.59
Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes. J Exp Med (1980) 1.58
On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J Exp Med (1987) 1.58
T-cell cytotoxicity in the absence of viral protein synthesis in target cells. Nature (1977) 1.57
SV40 T antigen and the exocytotic pathway. EMBO J (1985) 1.52
Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5'-triphosphate. Biochemistry (1996) 1.51
Addition of carbohydrate side chains at novel sites on influenza virus hemagglutinin can modulate the folding, transport, and activity of the molecule. J Cell Biol (1988) 1.50
The cellular response to unfolded proteins: intercompartmental signaling. Curr Opin Biotechnol (1994) 1.50
Proline isomerases function during heat shock. Proc Natl Acad Sci U S A (1993) 1.48
Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc Natl Acad Sci U S A (1992) 1.45
Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate. Science (1991) 1.44
Semliki forest virus temperature-sensitive mutants: isolation and characterization. Virology (1969) 1.42
Dimerization in MAP-kinase signaling. Trends Biochem Sci (2000) 1.40
X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. Biochemistry (1999) 1.39
Peptide-dependent stimulation of the ATPase activity of the molecular chaperone BiP is the result of conversion of oligomers to active monomers. J Biol Chem (1993) 1.38
Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus. J Virol (1992) 1.37
Conditional lethal mutants of rabbitpox virus. I. Isolation of host cell-dependent and temperature-dependent mutants. Virology (1966) 1.31
Role of specific simian virus 40 sequences in the nuclease-sensitive structure in viral chromatin. Mol Cell Biol (1985) 1.28
The structure of a Michaelis serpin-protease complex. Nat Struct Biol (2001) 1.27
kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust (2000) 1.22
Activity of the MAP kinase ERK2 is controlled by a flexible surface loop. Structure (1995) 1.22
Relative dependence of different outputs of the Saccharomyces cerevisiae pheromone response pathway on the MAP kinase Fus3p. Genetics (1999) 1.21
Production of simian virus 40 large tumor antigen in bacteria: altered DNA-binding specificity and dna-replication activity of underphosphorylated large tumor antigen. Proc Natl Acad Sci U S A (1989) 1.20
Molecular cloning and analysis of functional cDNA and genomic clones encoding bovine cellular retinoic acid-binding protein. Proc Natl Acad Sci U S A (1987) 1.19
A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family. J Biol Chem (1988) 1.17
Protein structure. Chaperones, paperones. Nature (1989) 1.16
Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prostacyclin, and prostaglandin E2 induction by lipopolysaccharide but not by tumor necrosis factor-alpha. J Immunol (1990) 1.16
BiP binding sequences in antibodies. J Biol Chem (1995) 1.16
Converting tissue plasminogen activator to a zymogen: a regulatory triad of Asp-His-Ser. Science (1993) 1.16
Identification of immunoglobulin heavy chain binding protein as glucose-regulated protein 78 on the basis of amino acid sequence, immunological cross-reactivity, and functional activity. J Cell Sci Suppl (1989) 1.16
Construction of intergeneric hybrids using bacteriophage P1CM: transfer of the Klebsiella aerogenes ribitol dehydrogenase gene to Escherichia coli. J Bacteriol (1976) 1.15
Mutating the charged residues in the binding pocket of cellular retinoic acid-binding protein simultaneously reduces its binding affinity to retinoic acid and increases its thermostability. Proteins (1992) 1.14
HSP70 binding sites in the tumor suppressor protein p53. J Biol Chem (1997) 1.14
Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A (1990) 1.13